Shenandoah Therapeutics

South San Francisco, CA · Founded 2022 · Privately Held (backing)

Developer of an oncology technology platform designed for cancer treatment. Shenandoah Therapeutics is based in South San Francisco, CA and was founded in 2022. Its last reported valuation was $37 million in Mar 2025. It has raised $21.5 million across 1 recorded round; the latest was a $21.5 million early-stage round in May 2025.

Last reported valuation
$37.0M
Oct 2026
Priced at
—
Total raised
$21.5M
Last round
Early Stage VC
May 2025
How much has Shenandoah Therapeutics raised?
$21.5Macross 1 recorded rounds · May 2025 – May 2025

Most recently, Shenandoah Therapeutics raised $21.5M in its Early Stage VC (May 2025).

Private Market View
More of Shenandoah Therapeutics with a free Private Market View account
  • ·Watch Shenandoah Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Shenandoah Therapeutics round by round

1 rounds
May 2025Early Stage VC$21.5MSEC filing▮
12 investors participated

How much has Shenandoah Therapeutics raised?

Shenandoah Therapeutics has raised $21.5 million across 1 recorded round since 2025. The largest was a $21.5 million early-stage round in May 2025.

Shenandoah Therapeutics has filed 1 Form D with the SEC, most recently in May 2025 ($21.5 million sold to 12 investors).

Shenandoah Therapeutics investors

5 investors are on record for Shenandoah Therapeutics, including Samsara BioCapital, Honghui Capital, First Spark Ventures and Time BioVentures. The early-stage round in May 2025 drew 12 investors.

For fundraisers
Raising for a company like Shenandoah Therapeutics?

5 investors have backed Shenandoah Therapeutics.

See all 5 investors →

Frequently asked about Shenandoah Therapeutics

How much has Shenandoah Therapeutics raised?
Shenandoah Therapeutics has raised $21.5M in total across 1 recorded funding rounds.
When was Shenandoah Therapeutics's last funding round?
Shenandoah Therapeutics's most recent recorded round was Early Stage VC in May 2025, raising $21.5M.